Related Experiment Video
Updated: Jun 18, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Neuromodulation for Vasovagal Syncope and Bradyarrhythmias
Asad Khan1, Henry D Huang1, Tolga Aksu2
1Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway, Chicago, IL 60612, USA.
Catheter-based neuromodulation offers a new way to treat vagal overactivity causing fainting and slow heart rates. This review guides patient selection, techniques, and outcomes for this innovative cardiac autonomic nervous system therapy.
Area of Science:
- Cardiology
- Autonomic Nervous System
- Medical Devices
Background:
- Catheter-based neuromodulation targets the intrinsic cardiac autonomic nervous system.
- This technique is used for vasovagal syncope and bradyarrhythmias due to vagal overactivity.
- Current lack of consensus on patient selection, techniques, and endpoints hinders widespread adoption.
Purpose of the Study:
- To provide a practical guide to neuromodulation for bradyarrhythmias.
- To focus on critical aspects: patient selection, evidence, and cardiac autonomic anatomy.
- To highlight mapping techniques, outcome measures, and future directions.
Main Methods:
- Review of current literature and clinical practices.
- Exploration of anatomical intricacies of the intrinsic cardiac autonomic nervous system.
- Discussion of various mapping techniques and established outcome measures.
Main Results:
- Neuromodulation is a promising therapy for specific bradyarrhythmias.
- Detailed insights into patient selection criteria are crucial for success.
- Understanding cardiac autonomic anatomy is key to effective procedural application.
Conclusions:
- Consensus on patient selection, technical steps, and endpoints is needed.
- Neuromodulation offers a viable alternative for managing vagal overactivity-related conditions.
- Further research and standardization will optimize the clinical use of this technique.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Heart Failure Drugs: β-Blockers
Mechanism of Cardiac Arrhythmias
Drugs Acting on Autonomic Ganglia: Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

